Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

[Advantages and prospects of the use of genetic vaccines for the protection from dangerous and socially significant infections].

Tutykhina IL, Shcherbinin DN, Shmarov MM, Logunov DIu, Naroditskiń≠ BS.

Vestn Ross Akad Med Nauk. 2011;(10):39-47. Review. Russian.

PMID:
22168038
2.

Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models.

Okada M, Okuno Y, Hashimoto S, Kita Y, Kanamaru N, Nishida Y, Tsunai Y, Inoue R, Nakatani H, Fukamizu R, Namie Y, Yamada J, Takao K, Asai R, Asaki R, Kase T, Takemoto Y, Yoshida S, Peiris JS, Chen PJ, Yamamoto N, Nomura T, Ishida I, Morikawa S, Tashiro M, Sakatani M.

Vaccine. 2007 Apr 20;25(16):3038-40. Epub 2007 Jan 23.

PMID:
17289225
4.

SARS vaccines: where are we?

Roper RL, Rehm KE.

Expert Rev Vaccines. 2009 Jul;8(7):887-98. doi: 10.1586/erv.09.43. Review.

PMID:
19538115
5.

Development of vaccines and passive immunotherapy against SARS coronavirus using mouse and SCID-PBL/hu mouse models.

Okada M, Takemoto Y, Okuno Y, Hashimoto S, Fukunaga Y, Tanaka T, Kita Y, Kuwayama S, Muraki Y, Kanamaru N, Takai H, Okada C, Sakaguchi Y, Furukawa I, Yamada K, Izumiya M, Yoshida S, Matsumoto M, Kase T, Peiris JS, DeMello DE, Chen PJ, Yamamoto N, Yoshinaka Y, Nomura T, Ishida I, Morikawa S, Tashiro M, Sakatani M.

Adv Exp Med Biol. 2006;581:561-6.

PMID:
17037598
6.

Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza.

Shoji Y, Chichester JA, Jones M, Manceva SD, Damon E, Mett V, Musiychuk K, Bi H, Farrance C, Shamloul M, Kushnir N, Sharma S, Yusibov V.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:41-50. Epub 2011 Jan 1.

PMID:
21266846
7.

New and emerging infectious diseases.

Spicuzza L, Spicuzza A, La Rosa M, Polosa R, Di Maria G.

Allergy Asthma Proc. 2007 Jan-Feb;28(1):28-34. Review.

PMID:
17390754
8.

Avian influenza: update.

Adams S, Sandrock C.

Med Princ Pract. 2010;19(6):421-32. doi: 10.1159/000320299. Epub 2010 Sep 28.

PMID:
20881408
9.

Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.

Luo M, Tao P, Li J, Zhou S, Guo D, Pan Z.

J Virol Methods. 2008 Dec;154(1-2):121-7. doi: 10.1016/j.jviromet.2008.08.011. Epub 2008 Sep 27.

PMID:
18789973
10.

The threat of avian influenza A (H5N1). Part IV: Development of vaccines.

Cinatl J Jr, Michaelis M, Doerr HW.

Med Microbiol Immunol. 2007 Dec;196(4):213-25. Epub 2007 Jun 1. Review.

PMID:
17541633
11.

Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.

Sandbulte MR, Jimenez GS, Boon AC, Smith LR, Treanor JJ, Webby RJ.

PLoS Med. 2007 Feb;4(2):e59.

12.

Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus.

Kim TW, Lee JH, Hung CF, Peng S, Roden R, Wang MC, Viscidi R, Tsai YC, He L, Chen PJ, Boyd DA, Wu TC.

J Virol. 2004 May;78(9):4638-45.

13.

Influenza vaccines: the virosome concept.

Wilschut J.

Immunol Lett. 2009 Feb 21;122(2):118-21. doi: 10.1016/j.imlet.2008.11.006. Epub 2008 Dec 25. Review.

PMID:
19100779
14.

Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity.

Buchholz UJ, Bukreyev A, Yang L, Lamirande EW, Murphy BR, Subbarao K, Collins PL.

Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9804-9. Epub 2004 Jun 21.

15.

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice.

Yang ZY, Kong WP, Huang Y, Roberts A, Murphy BR, Subbarao K, Nabel GJ.

Nature. 2004 Apr 1;428(6982):561-4.

PMID:
15024391
16.

[SARS vaccines].

Taguchi F.

Nihon Rinsho. 2008 Oct;66(10):1971-6. Review. Japanese.

PMID:
18939499
17.

Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines.

See RH, Petric M, Lawrence DJ, Mok CP, Rowe T, Zitzow LA, Karunakaran KP, Voss TG, Brunham RC, Gauldie J, Finlay BB, Roper RL.

J Gen Virol. 2008 Sep;89(Pt 9):2136-46. doi: 10.1099/vir.0.2008/001891-0.

PMID:
18753223
18.

A gene-based avian influenza vaccine in poultry.

Rao SS, Styles D, Kong W, Andrews C, Gorres JP, Nabel GJ.

Poult Sci. 2009 Apr;88(4):860-6. doi: 10.3382/ps.2008-00360.

PMID:
19276436
19.

[Tetravaccine--new fundamental approach to prevention of influenza pandemic].

Onishchenko GG, Zverev VV, Katlinskiń≠ AV, Semchenko AV, Korovkin SA, Mel'nikov SIa, Mironov AN.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Jul-Aug;(4):15-9. Review. Russian.

PMID:
17882832
20.

Humoral and cellular immune responses induced by 3a DNA vaccines against severe acute respiratory syndrome (SARS) or SARS-like coronavirus in mice.

Lu B, Tao L, Wang T, Zheng Z, Li B, Chen Z, Huang Y, Hu Q, Wang H.

Clin Vaccine Immunol. 2009 Jan;16(1):73-7. doi: 10.1128/CVI.00261-08. Epub 2008 Nov 5.

Items per page

Supplemental Content

Write to the Help Desk